The purpose of this study is to determine how effective Bleselumab is at preventing FSGS recurrence after transplant compared to the standard of care. Bleselumab is a drug traditionally used to prevent transplant rejection. Patients will undergo a screening period before their transplant date. The study intervention will happen during the kidney transplant procedure, and then participants will follow-up with the study team for 1 year.
How To Contact a Study Center:
- Visit KidneyHealthGateway.com to see if you might be eligible and to contact a study site near you